We are live on ! Find out more
HARP

Harpoon Therapeutics, Inc. Common Stock
HARP

Delisted

HARP was delisted on the 8th of March, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of HARP yet.

HARP Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Harpoon Therapeutics, Inc. Common Stock (HARP) for Q1 2024, worth a combined $0 — down 100% from $175M a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of HARP and 0 opened new positions — a net loss of 41 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Cormorant Asset Management, exiting entirely with an estimated $22.6M sold.

  • 0 institutional investors held Harpoon Therapeutics, Inc. Common Stock (HARP) as of Q1 2024, down from 41 in Q4 2023.
  • Funds reported $0 of Harpoon Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Harpoon Therapeutics, Inc. Common Stock positions in Q1 2024 and 41 closed out, a net change of -41 holders.
  • The largest Harpoon Therapeutics, Inc. Common Stock seller in Q1 2024 was Cormorant Asset Management, an estimated $22.6M sold.

Based on aggregated 13F filings for Q1 2024.